Emerging evidence suggests a compelling possibility for a synergistic connection between Alluvian and Retatrutide, representing a novel therapeutic here strategy for several metabolic diseases. Preliminary studies indicate that combining these two agents may yield improved efficacy compared to either alone, potentially treating a wider spectrum of